独轮车
发表于 2025-3-26 22:27:22
http://reply.papertrans.cn/59/5870/586908/586908_31.png
转换
发表于 2025-3-27 04:07:27
https://doi.org/10.1007/978-3-031-24575-6Lipoprotein(a); Metabolism; Apo(a); Isoforms; Antisense Therapy; Lipid Lowering Therapy; Risk factors; Card
阴险
发表于 2025-3-27 06:25:06
http://reply.papertrans.cn/59/5870/586908/586908_33.png
PACT
发表于 2025-3-27 12:05:46
Contemporary Cardiologyhttp://image.papertrans.cn/l/image/586908.jpg
arterioles
发表于 2025-3-27 16:50:33
978-3-031-24577-0The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
王得到
发表于 2025-3-27 20:16:56
Lipoprotein(a)978-3-031-24575-6Series ISSN 2196-8969 Series E-ISSN 2196-8977
食物
发表于 2025-3-28 01:15:40
http://reply.papertrans.cn/59/5870/586908/586908_37.png
迎合
发表于 2025-3-28 04:00:08
Role of Proprotein Convertase Subtilisin Kexin Type 9 in Lipoprotein(a) Metabolism,arch aimed at elucidating the role of PCSK9 in Lp(a) metabolism. Is the interaction between PCSK9 and Lp(a) particles LDLR dependent? What are the molecular mechanisms involved? This chapter aims at providing the key insights into the PCSK9-Lp(a) axis based on recent fundamental and clinical research findings.
Freeze
发表于 2025-3-28 09:05:22
http://reply.papertrans.cn/59/5870/586908/586908_39.png
REIGN
发表于 2025-3-28 12:41:43
http://reply.papertrans.cn/59/5870/586908/586908_40.png